|
ZNF268 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84960002869161E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.4780182046652E-12 |
| Normal-vs-Stage2 |
4.33369999996991E-06 |
| Normal-vs-Stage3 |
3.4623004463441E-10 |
| Normal-vs-Stage4 |
3.77164965925658E-12 |
| Stage1-vs-Stage2 |
6.054200E-01 |
| Stage1-vs-Stage3 |
6.988400E-02 |
| Stage1-vs-Stage4 |
3.996700E-04 |
| Stage2-vs-Stage3 |
7.683800E-02 |
| Stage2-vs-Stage4 |
4.219300E-03 |
| Stage3-vs-Stage4 |
1.454440E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12450002035069E-09 |
| Normal-vs-AfricanAmerican |
1.026870E-04 |
| Normal-vs-Asian |
1.67510000315119E-08 |
| Caucasian-vs-AfricanAmerican |
7.845400E-01 |
| Caucasian-vs-Asian |
7.219200E-01 |
| AfricanAmerican-vs-Asian |
6.114000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22540000369042E-09 |
| Normal-vs-Female |
3.60410001842837E-09 |
| Male-vs-Female |
4.361400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96510000494143E-08 |
| Normal-vs-Age(41-60Yrs) |
1.61000002218969E-09 |
| Normal-vs-Age(61-80Yrs) |
3.93809995724581E-09 |
| Normal-vs-Age(81-100Yrs) |
1.639370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.423000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.989000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.040400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.746600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.003800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.942800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.244100E-02 |
| Classical-VS-Follicular |
6.747200E-01 |
| Classical-VS-Other |
6.678200E-01 |
| Classical-VS-Normal |
3.24960000019914E-08 |
| Tall-VS-Follicular |
9.119800E-02 |
| Tall-VS-Other |
5.581800E-01 |
| Tall-VS-Normal |
9.79719971816451E-10 |
| Follicular-VS-Other |
8.003000E-01 |
| Follicular-VS-Normal |
1.09790000424326E-08 |
| Other-VS-Normal |
1.024060E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32940333688703E-11 |
| Normal-vs-N1 |
7.50119966141938E-11 |
| N0-vs-N1 |
2.520500E-02 |
|
|
